DB Fitzpatrick & Co Inc Boosts Stake in UnitedHealth Group Incorporated $UNH

DB Fitzpatrick & Co Inc raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,379 shares of the healthcare conglomerate’s stock after acquiring an additional 152 shares during the period. DB Fitzpatrick & Co Inc’s holdings in UnitedHealth Group were worth $742,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Financial Management Professionals Inc. grew its holdings in shares of UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after purchasing an additional 17 shares during the period. Global Wealth Strategies & Associates increased its holdings in shares of UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock worth $47,000 after buying an additional 20 shares during the last quarter. Retirement Planning Group LLC lifted its holdings in UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after acquiring an additional 21 shares during the last quarter. Net Worth Advisory Group increased its stake in UnitedHealth Group by 0.6% during the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock worth $1,907,000 after acquiring an additional 21 shares during the last quarter. Finally, Bensler LLC lifted its stake in shares of UnitedHealth Group by 0.3% in the 1st quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock valued at $3,637,000 after purchasing an additional 22 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent analyst reports. Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Bank of America upped their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research note on Monday, August 18th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, KeyCorp dropped their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $347.89 on Wednesday. The business has a 50-day simple moving average of $297.61 and a 200-day simple moving average of $362.39. The company has a market cap of $315.07 billion, a PE ratio of 15.07, a P/E/G ratio of 2.23 and a beta of 0.44. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the firm earned $6.80 EPS. The company’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.